Institutional investors purchased a net $5.1 million shares of NEO during the quarter ended June 2016. This may signal that the smart money is gaining interest in this company as the 58.80% of shares outstanding that institutional investors hold is actually below the Medical/Nursing Services industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SUMMIT CREEK ADVISORS LLC Bought 222.5 Thousand shares of Neogenomics Inc
CREDIT SUISSE AG Bought 16.5 Thousand shares of Neogenomics Inc
CREATIVE PLANNING, INC. Bought 3.0 Thousand shares of Neogenomics Inc